Tectonic Therapeutic, Inc.
TECX
$15.64
$0.583.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.64% | -28.55% | 30.16% | -39.82% | 16.75% |
| Total Depreciation and Amortization | -5.56% | -29.13% | 19.81% | 26.19% | -10.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.35% | 303.40% | -66.91% | -12.55% | -16.77% |
| Change in Net Operating Assets | 1,260.93% | 97.31% | -31.27% | -29.91% | -214.06% |
| Cash from Operations | -12.50% | 22.22% | 14.20% | -46.50% | -44.31% |
| Capital Expenditure | 100.00% | -800.00% | 98.04% | -3,925.00% | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 303.70% | -800.00% | 98.04% | -3,925.00% | 200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.54% | -2.61% | 4.17% | 1.64% | -3.39% |
| Issuance of Common Stock | -95.54% | -- | -- | -99.92% | 2,431,000.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 102.35% | -107.56% | 15,012.64% |
| Cash from Financing | -102.34% | 16,762.49% | 83.00% | -103.50% | 27,006.89% |
| Foreign Exchange rate Adjustments | -540.00% | -113.51% | 146.67% | -6.25% | 121.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.43% | 1,024.10% | 31.40% | -115.64% | 1,760.27% |